Cargando…

Significance of Specific Oxidoreductases in the Design of Hypoxia-Activated Prodrugs and Fluorescent Turn off–on Probes for Hypoxia Imaging

SIMPLE SUMMARY: Hypoxia-activated prodrugs (HAPs), selectively reduced by specific oxidoreductases under hypoxic conditions, form cytotoxic agents damaging the local cancer cells. On the basis of the reported clinical data concerning several HAPs, one can draw conclusions regarding their preclinical...

Descripción completa

Detalles Bibliográficos
Autores principales:	Janczy-Cempa, Ewelina, Mazuryk, Olga, Kania, Agnieszka, Brindell, Małgorzata
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9179281/ https://www.ncbi.nlm.nih.gov/pubmed/35681666 http://dx.doi.org/10.3390/cancers14112686

Ejemplares similares

Inhibition of Matrix Metalloproteinases and Cancer Cell Detachment by Ru(II) Polypyridyl Complexes Containing 4,7-Diphenyl-1,10-phenanthroline Ligands—New Candidates for Antimetastatic Agents
por: Gajda-Morszewski, Przemysław, et al.
Publicado: (2021)

Inhibition of Metastasis by Polypyridyl Ru(II) Complexes through Modification of Cancer Cell Adhesion – In Vitro Functional and Molecular Studies
por: Gurgul, Ilona, et al.
Publicado: (2022)

Variations in Reactive Oxygen Species Generation by Urban Airborne Particulate Matter in Lung Epithelial Cells—Impact of Inorganic Fraction
por: Mazuryk, Olga, et al.
Publicado: (2020)

Targeting Hypoxia: Hypoxia-Activated Prodrugs in Cancer Therapy
por: Li, Yue, et al.
Publicado: (2021)

The Hypoxia-Activated Prodrug TH-302: Exploiting Hypoxia in Cancer Therapy
por: Li, Yue, et al.
Publicado: (2021)

Selectively Targeting Tumor Hypoxia With the Hypoxia-Activated Prodrug CP-506
por: van der Wiel, Alexander M.A., et al.
Publicado: (2021)

Hypoxia-selective inhibition of angiogenesis development by NAMI-A analogues
por: Oszajca, Maria, et al.
Publicado: (2016)

From prodrug to pro-prodrug: hypoxia-sensitive antibody–drug conjugates
por: Wang, Yanming, et al.
Publicado: (2022)

Turn-on Fluorescent Biosensors for Imaging Hypoxia-like Conditions in Living Cells
por: Guisán-Ceinos, Santiago, et al.
Publicado: (2022)

Hypoxia-activated prodrugs and redox-responsive nanocarriers
por: Zeng, Yun, et al.
Publicado: (2018)

Nitroaromatic Hypoxia-Activated Prodrugs for Cancer Therapy
por: Denny, William A.
Publicado: (2022)

Carbon dots with molecular fluorescence and their application as a “turn-off” fluorescent probe for ferricyanide detection
por: Wang, Tianshu, et al.
Publicado: (2019)

Multifaceted interplay between lipophilicity, protein interaction and luminescence parameters of non-intercalative ruthenium(II) polypyridyl complexes controlling cellular imaging and cytotoxic properties
por: Mazuryk, Olga, et al.
Publicado: (2014)

Bioreductive prodrugs as cancer therapeutics: targeting tumor hypoxia
por: Guise, Christopher P., et al.
Publicado: (2014)

Studies Towards Hypoxia-Activated Prodrugs of PARP Inhibitors
por: Dickson, Benjamin D., et al.
Publicado: (2019)

In vitro radiosensitization of breast cancer with hypoxia‐activated prodrugs
por: Aiyappa‐Maudsley, Radhika, et al.
Publicado: (2022)

Antibody-Based Imaging of Bioreductive Prodrug Release in Hypoxia
por: Tosun, Çağla, et al.
Publicado: (2023)

A NIR fluorescent smart probe for imaging tumor hypoxia
por: Hettie, Kenneth S., et al.
Publicado: (2021)

A Nitronaphthalimide Probe for Fluorescence Imaging of Hypoxia in Cancer Cells
por: Kumari, Rashmi, et al.
Publicado: (2021)

Pronounced Hypoxia in Models of Murine and Human Leukemia: High Efficacy of Hypoxia-Activated Prodrug PR-104
por: Benito, Juliana, et al.
Publicado: (2011)

A Significant Fluorescence Turn-On Probe for the Recognition of Al(3+) and Its Application
por: Xing, Zhiyong, et al.
Publicado: (2022)

Targeting the hypoxic fraction of tumours using hypoxia-activated prodrugs
por: Phillips, Roger M.
Publicado: (2016)

Hypoxia-activated prodrugs: paths forward in the era of personalised medicine
por: Hunter, Francis W, et al.
Publicado: (2016)

Hypoxia-activated prodrug enhances therapeutic effect of sunitinib in melanoma
por: Liu, Shujing, et al.
Publicado: (2017)

The hypoxia-activated prodrug evofosfamide in combination with multiple regimens of radiotherapy
por: Nytko, Katarzyna J., et al.
Publicado: (2017)

Hypoxia-Activated Albumin-Binding Exatecan Prodrug for Cancer Therapy
por: Cheng, Zhiyang, et al.
Publicado: (2021)

Cyclin-Dependent Kinase Five Mediates Activation of Lung Xanthine Oxidoreductase in Response to Hypoxia
por: Kim, Bo S., et al.
Publicado: (2015)

Hypoxia-activated probe for NIR fluorescence and photoacoustic dual-mode tumor imaging
por: Li, Meng, et al.
Publicado: (2021)

Design of Optimized Hypoxia-Activated Prodrugs Using Pharmacokinetic/Pharmacodynamic Modeling
por: Foehrenbacher, Annika, et al.
Publicado: (2013)

Pyruvate sensitizes pancreatic tumors to hypoxia-activated prodrug TH-302
por: Wojtkowiak, Jonathan W, et al.
Publicado: (2015)

Leveraging Hypoxia-Activated Prodrugs to Prevent Drug Resistance in Solid Tumors
por: Lindsay, Danika, et al.
Publicado: (2016)

Microfluidics Formulated Liposomes of Hypoxia Activated Prodrug for Treatment of Pancreatic Cancer
por: Shah, Vidhi M., et al.
Publicado: (2022)

Hypoxia Imaging With PET Correlates With Antitumor Activity of the Hypoxia-Activated Prodrug Evofosfamide (TH-302) in Rodent Glioma Models
por: Stokes, Ashley M., et al.
Publicado: (2016)

Turn on Fluorescent Probes for Selective Targeting of Aldehydes
por: Dilek, Ozlem, et al.
Publicado: (2016)

CH-01 is a Hypoxia-Activated Prodrug That Sensitizes Cells to Hypoxia/Reoxygenation Through Inhibition of Chk1 and Aurora A
por: Cazares-Körner, Cindy, et al.
Publicado: (2013)

Hypoxia-activated prodrugs and (lack of) clinical progress: The need for hypoxia-based biomarker patient selection in phase III clinical trials
por: Spiegelberg, Linda, et al.
Publicado: (2019)

Turn-off mode fluorescent norbornadiene-based photoswitches
por: Tebikachew, Behabitu Ergette, et al.
Publicado: (2018)

A nitroreductase responsive and photoactivated fluorescent probe for dual-controlled tumor hypoxia imaging
por: Xu, Jialong, et al.
Publicado: (2022)

The Role of Bystander Effects in the Antitumor Activity of the Hypoxia-Activated Prodrug PR-104
por: Foehrenbacher, Annika, et al.
Publicado: (2013)

Targeting hypoxic microenvironment of pancreatic xenografts with the hypoxia-activated prodrug TH-302
por: Lohse, Ines, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_dud90geg82c0kd9560c2egc7fd